51.80 -0.12 (-0.23%)
Pre-Market: 8:15AM EDT
|Bid||51.80 x 4000|
|Ask||51.99 x 800|
|Day's Range||51.70 - 52.20|
|52 Week Range||42.99 - 52.20|
|Beta (3Y Monthly)||0.28|
|PE Ratio (TTM)||33.01|
|Earnings Date||Jul 23, 2019|
|Forward Dividend & Yield||1.60 (3.10%)|
|1y Target Est||52.00|
ATLANTA, June 25, 2019 /PRNewswire/ -- Coca-Cola North America is launching a digital marketplace this fall that connects its foodservice customers to pre-vetted, industry-best restaurant technologies with competitive pricing. The marketplace of solutions for front of house, back of house and outside of house is powered by Omnivore, a universal point-of-sale connectivity platform, that offers seamless integration into restaurants' point-of-sale (POS) systems. The marketplace is the result of a year-long collaboration between Coca-Cola and Omnivore and one output of Coca-Cola's investment in Omnivore, announced in late 2018.
Annual shareholder meetings and investor days are wrapped up for the year. And top Dow CEOs gave several useful insights to investors who were listening.
Coca-Cola (KO) gains from continued innovation and investment in core categories and brands. These traits have been bolstering its quarterly performances. However, currency headwinds remain.
Every sector of Georgia's economy that relies on imports from China will be affected by the potential new tariffs, according to the Georgia Association of Manufacturers
The beverage giant may be known as a reliable income stock, but here are a few better choices if you're looking for high yields.
PepsiCo experienced strong organic revenue growth of 5.2% in the first quarter driven mainly by the performance of its Frito-Lay North America segment. However, the company doesn’t expect this impressive rate of growth to continue in the remainder of 2019.
The U.S. Women's National Team fights back against gender-pay discrimination, while fighting for back-to-back World Cup titles in France.
The wishlist is long, with Atlanta already securing the NCAA Final Four for 2020 and Major League Baseball’s All-Star Game in 2021. But all these events come at a cost.
Shares of Canopy Growth (NYSE:CGC) are climbing on optimism that its deal for Acreage Holdings (OTCMKTS:ACRGF) will go through. On Wednesday the deal received CGC stock shareholder approval, just leaving regulators on the table for a potential headwind. We also have this afternoon's earnings to get through.Source: Shutterstock By and large, the deal is expected to go through, particularly given some of the board members involved. Acreage board members include former Republican Congressman and Speaker of the United States House John Boehner and Brian Mulroney, the former Conservative Prime Minister of Canada -- among others.Many expect the $3.4 billion cash and stock deal to go through, leaving Canopy with a big asset for future growth here in the U.S.InvestorPlace - Stock Market News, Stock Advice & Trading TipsWhen investors think of blue-chip stocks, Canopy won't be the first that comes to mind. Procter & Gamble (NYSE:PG), Coca-Cola (NYSE:KO) and others are what investors think of, but that doesn't matter. CGC stock has quickly proven that it's the best of the best when it comes to cannabis investments. Canopy Growth Is a Blue Chip StockAfter Constellation Brands (NYSE:STZ) invested some $4 billion into the company, it loaded CGC's bank account. But the deal gave Canopy a lot more than a good reputation. Suddenly, it had a powerful balance sheet as a major asset. It could afford to enter new markets, gobble up high-growth companies and essentially lead the land-grab charge as cannabis gains momentum. Further yet, it had a high-quality and reputable company staking big-time money on Canopy's leadership. That gives the company some clout. * Check Out These 5 Fast-Growing Stocks to Buy Today If Constellation trusts Canopy with $4+ billion, why shouldn't I? That's what a lot of investors and other companies found themselves asking.CGC stock has built a foundation in Canada and is working on global expansion in Europe and Australia, while its Acreage Holdings deal positions itself for the coming landslide in the U.S. While its valuation doesn't quite reflect its current fundamentals, investors are betting on its long-term potential.In essence, they are betting that CGC will become the PepsiCo (NYSE:PEP) or Coca-Cola of its industry. That's not to say New Age Beverages (NASDAQ:NBEV), Aurora Cannabis (NYSE:ACB) or Cronos Group (NYSE:CRON) won't be winners either. Just that CGC is becoming the 800-lb gorilla of the group.From the most recent earnings release:"Our successful first full quarter with recreational sales in Canada reinforces our long held strategy of making meaningful investments early in order to secure market share," said Bruce Linton, Chairman & Co-CEO, Canopy Growth. "With a strong cash position, we added strategic assets and IP through acquisitions to accelerate the sophistication of our inputs with ebbu, and our consumer-facing outputs with Storz and Bickel." Trading CGC Stock Click to EnlargeCGC stock is now pushing through its 20-day and 200-day moving averages. If it can continue to push higher, its 50-day moving average near $44.50 is in sight. This stock has been volatile, but continues to very slowly push out new highs.Unfortunately, those new highs are often met with a wave of selling. For instance, after hitting $52 in February, Canopy Growth stock quickly retreated, falling to sub-$42 -- a 19% drop -- in just six trading sessions. It traded sideways for a while after that, before eventually pushing up through $52. A month later, shares were at $38.38. The peak to trough decline was more than 27% that time.So what can we expect on this go around? Much of it will depend on earnings, set for after the close on June 20th.I'm looking to see if CGC stock price can again climb back to $52. If it can, it will represent a 20% rally from current levels. As we said above, Canopy stock is a blue chip name among the cannabis industry. If this group regains momentum, so too should CGC. Earnings may be the spark for that momentum, but we won't know until Friday morning. * 6 Stocks Ready to Bounce on a Trade Deal If the earnings results inspire investors to gobble up CGC stock, upside targets of $48 and $52 are within reach. If the reaction is negative or if the 50-day acts as resistance, I'm looking for support near $40. Below opens the door to some serious declines, but let's not get ahead of our skis. Let's see the report before going any further.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Blue-Chip Stocks to Buy for a Noisy Market * 5 Strong Buy Biotech Stocks for the Second Half * 6 Stocks Ready to Bounce on a Trade Deal Compare Brokers The post The Blue Chip of Pot: Can CGC Stock Rally 20% on Acreage Deal and Earnings? appeared first on InvestorPlace.
The Coca-Cola Company today announced it will release second quarter 2019 financial results on July 23 before the New York Stock Exchange opens. The release will be followed by an investor conference call at 8:30 a.m.
Back in 2002 Stephen J. Errico, a Wall Street investor, who now has more than 30 years of professional investing experience, launched his own NYC-based hedge fund, Locust Wood Capital Advisers. Aside from being the fund's founder he is also its CIO and Controling Principal. Previously, Mr. Errico worked at Morgan Stanley as a portfolio […]
Yorkshire’s small business owners no longer think “where there’s muck, there’s brass”. Or so market research by Clydesdale and Yorkshire Banking Group would seem to suggest. Straight-talking Yorkshire pragmatism is out.
When folks think of the Berkshire Hathaway (BRK.B) portfolio and its collection of holdings, most of which were selected by Chairman and CEO Warren Buffett, the companies that most readily come to mind are probably American Express (AXP), Coca-Cola (KO) and, more recently, Apple (AAPL).But a deep dive into Berkshire Hathaway's equity holdings reveals a more complicated picture.Berkshire Hathaway held positions in 48 separate stocks as of March 31, according to regulatory filings with the Securities and Exchange Commission. But the portfolio of "Buffett stocks" isn't as diversified as the number might suggest. In some cases, BRK.B holds more than one share class in the same company. Some holdings are so small as to be immaterial leftovers from earlier bets the Oracle of Omaha has yet to completely exit.And perhaps most importantly, Berkshire Hathaway's equity portfolio is actually pretty concentrated. The top six holdings account for almost 70% of the portfolio's total value. The top 10 positions comprise nearly 80%. Banks and airlines, to cite a couple of sectors, carry quite a load in this portfolio. Then there's the fact that several Buffett stocks actually were picked by portfolio managers Todd Combs and Ted Weschler.Here, we examine each and every holding to give investors a better understanding of the entire Berkshire Hathaway portfolio. SEE ALSO: The 19 Best Stocks to Buy for the Rest of 2019
BMO Capital Markets lifted its price target on the beverage maker’s stock citing an upbeat growth outlook for the coming years.
In a frothy market you can get a mighty high multiple if you're in the right niche. Like marijuana. That's the story of New Age Beverages (NASDAQ:NBEV). NBEV stock tripled last September after announcing a drink containing CBD. Its drinks even have a picture of the late Bob Marley on them.But pot isn't NBEV's real business. Canned beverages are its business. Things like coffee, tea and kombucha. Sodas with strange combinations like watermelon and coconut, the kind of stuff you'll try at a soda ranch on Route 66.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSince that September explosion, where it briefly traded at almost $9, NBEV stock has lost its fizz, settling into a trading range of between $4-6 per share. But its market cap, $350 million, remains impressive for a drinks company with March quarter sales of $58 million, and no profit.But still. Pot! What NBEV Is Up ToNew Age Beverages has used its moment in the pot limelight to bulk up the product line. The highlight was this month's purchase of Brands Within Reach, for $6.4 million, only $500,000 of it cash. * 7 Top-Rated Biotech Stocks to Invest In Today Brands Within Reach has brand licensing and distribution rights for some mainstream beverages, like cold Nestea and Illy coffee. The idea is that this gets New Age in the door at mainstream retailers like Walmart (NYSE:WMT) and Costco Wholesale (NASDAQ:COST), which then might look at its more esoteric brands.This came just six months after buying Morinda Holdings, another small company but with distribution in 60 countries. The idea there was to expand the market for its CBD products.The Morinda combination is already in the numbers due to be reported August 8, where sales of $70.8 million are expected. Following on the first quarter take of $58 million, that's good growth and, if the pattern persists through the year, it could lead to sales equaling the stock's current market cap by this time next year.That's important, because New Beverage CEO Brent Willis knows he's in the drinks business, not the pot business. He promised to focus on execution after buying Morinda, but the chance to buy into serious beverages with just stock was too good to pass up. What Next for NBEV Stock?Some analysts got very bullish on New Age after the Morinda buy, predicting imminent profits and a steady rise to $9 per share, which would be double its current level.InvestorPlace's Josh Enomoto disagrees. He sees the Brands Within Reach acquisition as a turn away from CBD, the source of its frothy valuation. He also sees the current brands as nothing special.Personally, I like the Brands Within Reach deal. NBEV now has both brands that can get it into the door of big retailers and global distribution for its CBD products. But drinks remain a risky business, a land of giants in which NBEV is a mouse. If Coca-Cola (NYSE:KO), Pepsico (NYSE:PEP) or even Keurig Dr Pepper (NYSE:KDP) decided there was something to this CBD thing, they could blow NBEV out of the water quickly. The Bottom Line on NBEV StockI think the owners of Brands Within Reach know all this, so there's an overhang of almost $6 million in stock, itching to be sold right now.Much of the rest of the common stock is held by speculators looking for a quick payout. Institutions hold just over 13% of the common, against almost 26% held by insiders. I think they will bail, too, at the first sign of bad news. * 7 Top-Rated Biotech Stocks to Invest In Today In other words, NBEV stock has a sell-by date, and execution alone won't stave it off.Dana Blankenhorn is a financial and technology journalist. He is the author of the mystery thriller, The Reluctant Detective Finds Her Family, available at the Amazon Kindle store. Write him at email@example.com or follow him on Twitter at @danablankenhorn. As of this writing he owned no shares in companies mentioned in this article. Compare Brokers The post NBEV Stock Is More Than Just CBD -- But It's Still Not Enough appeared first on InvestorPlace.
Opportunity lies with low and falling interest rates, says Mark DiOrio of Brookstone Capital Management. You just need to position yourself right.
U.S. Soccer Foundation President and CEO Ed Foster-Simeon discusses their new partnership with Powerade, as well as the success of the United States Women's National Team as they look to win the FIFA Women's World Cup this year in France. He joins Yahoo Finance's Zack Guzman and Kristin Myers, along with Carleton English, NY Post Hedge Fund Reporter.